Ancora Advisors’s bluebird bio BLUE Stock Holding History

Ancora Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4	Closed	-$238	–	1809
2023 Q1	$238	Buy	+4	New	+$457	﹤0.01%	1814

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Ancora Advisors's BLUE Position: Q2 2023 in Review

Ancora Advisors sold out of bluebird bio (BLUE) in Q2 2023, closing a stake of 4 shares — an estimated $238 sold.

Ancora Advisors first reported a position in BLUE in Q1 2023 and held it in 1 quarter. The position peaked at $238 in Q1 2023. 175 funds tracked by Wall St. Rank hold BLUE as of Q2 2023.

Ancora Advisors reported no remaining bluebird bio position as of Q2 2023 after selling out during the quarter.
Ancora Advisors sold 4 bluebird bio shares in Q2 2023, an estimated $238.
Ancora Advisors first reported a position in bluebird bio in Q1 2023 and held it in 1 quarter.
Ancora Advisors's bluebird bio position peaked at $238 in Q1 2023.
175 funds tracked by Wall St. Rank held bluebird bio as of Q2 2023.

Based on Ancora Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.